Anavex Life Sciences Corp (AVXL)

[biotechnician]

Mentioned on Conference Call :
1. Enough cash for 2 years along with assistance from Australian Government.
2. PDD Topline results will be a 2019 event.
3. response from sponsor for phase 3 design in Rhetts assisted by Walter Kauffman
4. PDD 1/3 enrolled, steady enrollment. possible acceleration
5. Review boards for first 3 sites for Rhetts and adding more.
6. Pleased with AD patients screened. ( No one asked but I hoped the 80 screened patients included those with biomarkers discovered)

I think more of us private investors would listen to CC and ask questions that we pose on this board.